716 related articles for article (PubMed ID: 15106798)
1. Relationship between ambulatory blood pressure and follow-up clinic blood pressure in elderly patients with systolic hypertension.
Fagard RH; Staessen JA; Thijs L; Bulpitt CJ; Clement D; de Leeuw PW; Jääskivi M; Mancia G; O'Brien E; Palatini P; Tuomilehto J; Webster J;
J Hypertens; 2004 Jan; 22(1):81-7. PubMed ID: 15106798
[TBL] [Abstract][Full Text] [Related]
2. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population.
Pringle E; Phillips C; Thijs L; Davidson C; Staessen JA; de Leeuw PW; Jaaskivi M; Nachev C; Parati G; O'Brien ET; Tuomilehto J; Webster J; Bulpitt CJ; Fagard RH;
J Hypertens; 2003 Dec; 21(12):2251-7. PubMed ID: 14654744
[TBL] [Abstract][Full Text] [Related]
3. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
4. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
5. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J
JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715
[TBL] [Abstract][Full Text] [Related]
6. Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring.
Staessen JA; Beilin L; Parati G; Waeber B; White W
Blood Press Monit; 1999 Dec; 4(6):319-31. PubMed ID: 10602536
[TBL] [Abstract][Full Text] [Related]
7. Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults.
Hermida RC; Smolensky MH; Ayala DE; Portaluppi F
Chronobiol Int; 2015; 32(10):1329-42. PubMed ID: 26587588
[TBL] [Abstract][Full Text] [Related]
8. Sequential follow-up clinic and ambulatory blood pressure evaluation in a low risk population of white-coat hypertensive patients and in normotensives.
Polónia JJ; Gama GM; Silva JA; Amaral C; Martins LR; Bertoquini SE
Blood Press Monit; 2005 Apr; 10(2):57-64. PubMed ID: 15812251
[TBL] [Abstract][Full Text] [Related]
9. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
[TBL] [Abstract][Full Text] [Related]
10. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
[TBL] [Abstract][Full Text] [Related]
11. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension.
Fagard RH; Celis H; Thijs L; Staessen JA; Clement DL; De Buyzere ML; De Bacquer DA
Hypertension; 2008 Jan; 51(1):55-61. PubMed ID: 18039980
[TBL] [Abstract][Full Text] [Related]
12. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
13. Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white-coat' effect. Syst-Eur investigators.
Parati G; Omboni S; Staessen J; Thijs L; Fagard R; Ulian L; Mancia G
J Hypertens; 1998 Jan; 16(1):23-9. PubMed ID: 9533413
[TBL] [Abstract][Full Text] [Related]
14. Blood Pressure Monitoring. Task force III: Target-organ damage, morbidity and mortality.
Verdecchia P; Clement D; Fagard R; Palatini P; Parati G
Blood Press Monit; 1999 Dec; 4(6):303-17. PubMed ID: 10602535
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
Lacourcière Y; Asmar R
Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension.
Staessen JA; Thijs L; O'Brien ET; Bulpitt CJ; de Leeuw PW; Fagard RH; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J; Safar ME;
Am J Hypertens; 2002 Oct; 15(10 Pt 1):835-43. PubMed ID: 12372669
[TBL] [Abstract][Full Text] [Related]
17. Prediction of blood pressure level and need for antihypertensive medication: 10 years of follow-up.
Jokiniitty JM; Majahalme SK; Kähönen MA; Tuomisto MT; Turjanmaa VM
J Hypertens; 2001 Jul; 19(7):1193-201. PubMed ID: 11446708
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements. Multicenter Study Investigators.
Omboni S; Zanchetti A
J Hypertens; 1998 Dec; 16(12 Pt 1):1831-8. PubMed ID: 9869018
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension.
Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Cléroux J; Boileau G
Am J Hypertens; 1995 Dec; 8(12 Pt 1):1154-9. PubMed ID: 8998248
[TBL] [Abstract][Full Text] [Related]
20. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
Hermida RC; Ayala DE; Fernández JR; Mojón A
Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
